SMG » Topics » The Scotts Miracle-Gro Company

This excerpt taken from the SMG 8-K filed Apr 28, 2009.
The Scotts Miracle-Gro Company
(Exact name of registrant as specified in its charter)
 
Ohio
 
1-11593
 
31-1414921
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 
14111 Scottslawn Road, Marysville, Ohio 43041
(Address of principal executive offices) (Zip Code)
 
(937) 644-0011
(Registrant’s telephone number, including area code)
 
Not applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
This excerpt taken from the SMG 8-K filed Feb 3, 2009.
The Scotts Miracle-Gro Company
(Exact name of registrant as specified in its charter)
 
Ohio
 
1-13292
 
31-1414921
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification No.)
 
14111 Scottslawn Road, Marysville, Ohio 43041
(Address of principal executive offices) (Zip Code)
 
(937) 644-0011
(Registrant’s telephone number, including area code)
 
Not applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 



 
This excerpt taken from the SMG DEF 14A filed Dec 19, 2008.
The Scotts Miracle-Gro Company
Proxy Statement for 2009 Annual Meeting of Shareholders
 


Table of Contents

(THE SCOTTS MIRACLE-GRO COMPANY LOGO)
 
14111 Scottslawn Road
Marysville, Ohio 43041
December 19, 2008
 
 
Dear Fellow Shareholders:
 
The Annual Meeting of Shareholders of The Scotts Miracle-Gro Company will be held at 8:30 a.m., Eastern Time, on Thursday, January 22, 2009, at The Berger Learning Center, 14111 Scottslawn Road, Marysville, Ohio 43041. The formal Notice of Annual Meeting of Shareholders and Proxy Statement contain detailed information about the business to be conducted at the Annual Meeting.
 
On behalf of the Board of Directors and management, I invite you to attend the Annual Meeting.
 
The Board of Directors has nominated three directors for election, each to serve for a term of three years expiring at the 2012 Annual Meeting of Shareholders (Proposal Number 1). The Board of Directors recommends that you vote FOR each of the nominees.
 
This year, you are also being asked to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2009 (Proposal Number 2). The Board of Directors recommends that you vote FOR the ratification of this selection.
 
Only shareholders of record at the close of business on November 26, 2008, are entitled to receive notice of and to vote at the Annual Meeting.
 
Whether or not you plan to attend the Annual Meeting, please record your vote on the accompanying form of proxy and return it promptly in the postage-paid envelope provided. Alternatively, if you are a registered shareholder, you may transmit voting instructions for your Common Shares electronically via the Internet or telephonically by following the specific instructions on your form of proxy.
 
Sincerely,
 
-s- James Hagedorn
James Hagedorn
These excerpts taken from the SMG 10-K filed Dec 3, 2008.
The Scotts Miracle-Gro Company
(Exact name of registrant as specified in its charter)
 
 
     
Ohio   31-1414921
     
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     
14111 Scottslawn Road, Marysville, Ohio
  43041
     
(Address of principal executive offices)   (Zip Code)
 
Registrant’s telephone number, including area code:  937-644-0011
 
Securities registered pursuant to Section 12(b) of the Act:
 
 
     
Title of Each Class
 
Name of Each Exchange On Which Registered
 
Common Shares, without par value
  New York Stock Exchange
 
Securities registered pursuant to Section 12(g) of the Act: None
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes þ     No o
 
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes o     No þ
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ     No o
 
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  þ
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer þ Accelerated filer o Non-accelerated filer o Smaller reporting company o
(Do not check if a smaller reporting company)
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes o     No þ
 
The aggregate market value of Common Shares (the only common equity of the registrant) held by non-affiliates of the registrant computed by reference to the price at which Common Shares were last sold as of the last business day of the registrant’s most recently completed second fiscal quarter (March 28, 2008) was approximately $1,410,465,487.
 
Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date: The number of Common Shares of the registrant outstanding as of November 21, 2008 was 65,373,940.
 
The Scotts
Miracle-Gro Company






(Exact name of registrant as
specified in its charter)



 


 













































     

Ohio

 

31-1414921

 

 

 

(State or other jurisdiction of
incorporation or organization)


 

(I.R.S. Employer Identification No.)


 

 

 


14111 Scottslawn Road, Marysville, Ohio


 

43041

 

 

 

(Address of principal executive
offices)


 

(Zip Code)







 



Registrant’s telephone number, including area
code:  937-644-0011


 



Securities registered pursuant to Section 12(b) of the Act:


 


 























     


Title of Each Class


 


Name of Each Exchange On Which Registered

 


Common Shares, without par value


 

New York Stock Exchange






 



Securities registered pursuant to Section 12(g) of the Act:
None


 



Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act.  Yes þ     No o



 



Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act.  Yes o     No þ



 



Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days.  Yes þ     No o



 



Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
(§ 229.405 of this chapter) is not contained herein,
and will not be contained, to the best of registrant’s
knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this
Form 10-K
or any amendment to this
Form 10-K.  þ



 



Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
“large accelerated filer,” “accelerated
filer” and “smaller reporting company” in
Rule 12b-2
of the Exchange Act.


 


















Large accelerated
filer þ
Accelerated
filer o

Non-accelerated
filer o
Smaller reporting
company o





(Do not check if a smaller reporting company)


 



Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the
Act).  Yes o     No þ



 



The aggregate market value of Common Shares (the only common
equity of the registrant) held by non-affiliates of the
registrant computed by reference to the price at which Common
Shares were last sold as of the last business day of the
registrant’s most recently completed second fiscal quarter
(March 28, 2008) was approximately $1,410,465,487.


 



Indicate the number of shares outstanding of each of the
registrant’s classes of common stock, as of the latest
practicable date: The number of Common Shares of the registrant
outstanding as of November 21, 2008 was 65,373,940.


 




These excerpts taken from the SMG 10-K filed Nov 25, 2008.
The Scotts Miracle-Gro Company
(Exact name of registrant as specified in its charter)
 
 
     
Ohio   31-1414921
     
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     
14111 Scottslawn Road, Marysville, Ohio
  43041
     
(Address of principal executive offices)   (Zip Code)
 
Registrant’s telephone number, including area code:     937-644-0011
 
Securities registered pursuant to Section 12(b) of the Act:
 
 
     
Title of Each Class
 
Name of Each Exchange On Which Registered
 
Common Shares, without par value
  New York Stock Exchange
 
Securities registered pursuant to Section 12(g) of the Act: None
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes 
The Scotts
Miracle-Gro Company






(Exact name of registrant as
specified in its charter)



 


 













































     

Ohio

 

31-1414921

 

 

 

(State or other jurisdiction of
incorporation or organization)


 

(I.R.S. Employer Identification No.)


 

 

 


14111 Scottslawn Road, Marysville, Ohio


 

43041

 

 

 

(Address of principal executive
offices)


 

(Zip Code)







 



Registrant’s telephone number, including area
code:     937-644-0011


 



Securities registered pursuant to Section 12(b) of the Act:


 


 























     


Title of Each Class


 


Name of Each Exchange On Which Registered

 


Common Shares, without par value


 

New York Stock Exchange






 



Securities registered pursuant to Section 12(g) of the Act:
None


 



Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined in Rule 405 of the Securities
Act.  Yes 
This excerpt taken from the SMG 8-K filed Sep 17, 2008.
The Scotts Miracle-Gro Company
(Exact name of registrant as specified in its charter)
         
Ohio   1-13292   31-1414921
         
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer
Identification No.)
14111 Scottslawn Road, Marysville, Ohio 43041
(Address of principal executive offices) (Zip Code)
(937) 644-0011
(Registrant’s telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 7.01. Regulation FD Disclosure.
As part of the ongoing governmental investigation previously disclosed by The Scotts Miracle-Gro Company (the “Company”), the Company and certain of its subsidiaries received Stop Sale, Use or Removal Orders (“SSUROs”) on September 12, 2008 from the U.S. Environmental Protection Agency (“USEPA”) with respect to several products including “Season Long Max Weed and Grass Killer Plus Preventer,” “Weed B Gon Lawn Weed Killer,” “Weed B Gon Max Plus Crabgrass Control Singles,” “Ortho® Roach, Ant and Spider Killer,” “Winterizer with Plus 2 Weed Control,” and certain Smith & Hawken® citronella oil. The Company was not shipping these products at the time the SSUROs were issued. The SSUROs do not apply to the Company’s customers or consumers.
Given the Company’s previous self disclosures on these products to the USEPA, the SSUROs were not unexpected. The Company was encouraged that the SSUROs provide the Company the ability to relabel the affected products so that it may resume shipping the products.
The Company does not expect the impact from the delayed shipments of the products subject to the SSUROs to have a material impact on its financial results for fiscal year 2008 or fiscal year 2009. Collectively, these products represent less than 1% of the Company’s sales. Currently, the Company expects costs related to all product recalls and known registration issues related to the ongoing investigation to range from $50 to $55 million in fiscal year 2008 and approximately $10 million in fiscal year 2009. Those estimates are exclusive of potential fines and/or penalties. No reserves have been established with respect to any potential civil or criminal fines or penalties at the state and/or federal level related to such issues as the scope and magnitude of such amounts are not currently estimable. However, it is possible that such fines and/or penalties could be material and have an adverse effect on the Company’s financial condition and results of operations.
As also previously disclosed, the Company expects that the ongoing governmental investigation will result in the identification of additional product compliance issues. Accordingly, the USEPA may, among other things, issue additional stop sale orders. Such stop sale orders, if they are issued, will be publicly available documents; however, unless the Company considers the products addressed by any one or more of such stop sale orders to merit disclosure on a current basis, the Company intends to address updates with respect to the third-party review pursuant to the Compliance Review Plan and any USEPA actions in the Company’s periodic reports.
For more information with respect to additional risks and uncertainties the Company may face in connection with the ongoing investigation, please see the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 28, 2008.

- 2 -


 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
             
    THE SCOTTS MIRACLE-GRO COMPANY    
 
           
Dated: September 17, 2008
  By:   /s/ David C. Evans
 
   
    Printed Name: David C. Evans    
    Title: Executive Vice President and Chief Financial Officer    

- 3 -

This excerpt taken from the SMG 8-K filed Jun 4, 2008.
The Scotts Miracle-Gro Company
(Exact name of registrant as specified in its charter)
         
Ohio   1-13292   31-1414921
         
(State or other jurisdiction of   (Commission File Number)   (IRS Employer
incorporation)       Identification No.)
  14111 Scottslawn Road, Marysville, Ohio 43041  
  (Address of principal executive offices) (Zip Code)  
 
  (937) 644-0011  
  (Registrant’s telephone number, including area code)  
         
  Not applicable  
  (Former name or former address, if changed since last report)  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 8.01. Other Events.
On May 23, 2008, The Scotts Miracle-Gro Company (the “Company”) agreed with the U.S. Environmental Protection Agency (“USEPA”) on a Compliance Review Plan (the “Plan”) for conducting a comprehensive, independent review of the Company’s pesticide product registration records. The Plan was developed by the Company in cooperation with the USEPA in connection with the USEPA’s previously disclosed, on-going investigation into the accuracy and/or validity of the Company’s pesticide product registrations. The Company believes that previously disclosed discrepancies in its registration records were the result of the actions of a former associate of the Company who apparently deliberately circumvented Company policies and USEPA regulations. The Company takes full responsibility for ensuring that each of its products meets all federal and state regulations and is safe for consumer use and looks forward to initiating the extensive review process contemplated by the Plan and to continuing to work in cooperation with the USEPA to clarify and remedy these issues.
Pursuant to the Plan, the Company has provided the USEPA with its recommendation for the appointment of a third-party firm to conduct the review. Upon approval of this firm by the USEPA, the third-party reviewer will perform a compliance review in two phases: Phase 1 will cover all pesticide products that the Company distributed or sold after May 1, 2003, commencing with the most recent distribution and sales dates and including the review of related product information from January 1, 1998 to the present. Under the Plan, the scope of Phase 1 will concern labels, labeling, advertising and composition. Phase 2 of the Plan will cover the Company’s pesticide products not included in Phase 1 that were registered with the USEPA as of April 1, 2008. The third-party reviewer is required to complete its compliance review within 120 days after the USEPA’s approval of the appointment of such third-party reviewer, subject to possible extension in the USEPA’s sole discretion upon a written request from the third-party reviewer or the Company.
The third-party reviewer will review Phase 1 and Phase 2 pesticide products to identify any products that, after May 1, 2003: (1) were not properly registered with the USEPA; (2) contained improper labels; (3) were the subject of incorrect, invalid, inconsistent, false, fraudulent or misleading statements, documents or representations by the Company to the USEPA or any state; or (4) otherwise failed to comply with USEPA regulations or the Federal Insecticide, Fungicide and Rodenticide Act, as amended (“FIFRA”). For each pesticide product reviewed, the third-party reviewer is required to submit, on a rolling basis, a separate review report to each of the USEPA and the Company simultaneously, without any pre-review by the Company, describing any applicable compliance issues. If a review report determines that there is an applicable compliance issue, the Company will have 10 days to propose to the USEPA in writing a corrective action and the date when the proposed action, if any, will be completed. The third-party reviewer’s conclusions and review report regarding a pesticide product will not bind either the Company or the USEPA, and either party will have the right to dispute any of the third-party reviewer’s conclusions or review reports.
The third-party review contemplated by the Plan is in addition to the previously disclosed investigation initiated by the Company into the Company’s product registrations. The Company is also continuing to cooperate with the U.S. Department of Justice in connection with the previously disclosed, related criminal investigation.
In addition to the previously disclosed registration issues, the Company has discovered, and disclosed to the USEPA, certain discrepancies in its registration records with respect to several additional products and will continue to work with the USEPA to address and correct these and any subsequently discovered discrepancies. Either the investigation initiated by the Company or the third-party review contemplated by the Plan may result in the discovery of further discrepancies and may result in future state or federal action with respect to existing or additional product registration issues. Until these investigations are complete, the Company cannot fully quantify the scope or extent of additional issues. As also previously disclosed, the Company may be subject to civil or criminal fines or penalties, or other enforcement action, at the state and/or federal level as a result of these product registration issues. It is possible that such fines and/or penalties could be material and have an adverse effect on the Company’s financial condition and results of operations.
For more information with respect to additional risks and uncertainties the Company may face in connection with the USEPA investigation and the related criminal investigation by the U.S. Department of Justice, please see the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 29, 2008. The Company intends to address updates with respect to the Company-initiated investigation and the third-party review pursuant to the Plan in the Company’s periodic reports.

-2-


 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  THE SCOTTS MIRACLE-GRO COMPANY
 
 
Dated: June 4, 2008  By:   /s/ Vincent C. Brockman   
  Printed Name:   Vincent C. Brockman   
  Title:  Executive Vice President, General Counsel and Corporate Secretary   

-3-

This excerpt taken from the SMG 8-K filed Apr 25, 2008.
The Scotts Miracle-Gro Company
(Exact name of registrant as specified in its charter)
         
Ohio   1-13292   31-1414921
         
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)
14111 Scottslawn Road, Marysville, Ohio 43041
 
(Address of principal executive offices) (Zip Code)
(937) 644-0011
 
(Registrant’s telephone number, including area code)
Not applicable
 
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 7.01.   Regulation FD Disclosure.
On April 24, 2008, The Scotts Miracle-Gro Company (the “Company”) issued a press release announcing that it had initiated a series of proactive steps aimed at strengthening its product registration practices and procedures with state and federal regulatory agencies and announcing the recall of its Bonus S Max and Turf Builder Plus 2 Max fertilizer products from retail customers and consumers. The two products together represent less than 1% of the Company’s total sales.
The Company is still in the process of determining the cost of this product recall but currently believes that it will be in the range of $5 million to $10 million, which is incremental to the previously disclosed estimated product recall costs associated with the consumer recall of the Miracle-Gro® Shake ‘n Feed with Weed Preventer All Purpose Plant Food product and Scotts LawnServices product.
A copy of the Company’s press release is attached to this Form 8-K as Exhibit 99.1.
Item 9.01.   Financial Statements and Exhibits.
     (a)  Financial statements of businesses acquired:
                    Not applicable.
     (b) Pro forma financial information :
                    Not applicable.
     (c) Shell company transactions:
                    Not applicable.
     (d) Exhibits:
         
Exhibit No.   Description
       
 
  99.1    
News Release issued by The Scotts Miracle-Gro Company on April 24, 2008

-2-


 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  THE SCOTTS MIRACLE-GRO COMPANY
 
 
Dated: April 25, 2008  By:   /s/ David C. Evans    
    Name:   Printed David C. Evans   
    Title:   Executive Vice President and Chief Financial Officer   
 

-3-


 

INDEX TO EXHIBITS
Current Report on Form 8-K
Dated April 25, 2008
The Scotts Miracle-Gro Company
         
Exhibit No.   Description
       
 
  99.1    
News Release issued by The Scotts Miracle-Gro Company on April 24, 2008

-4-

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki